Clonal expansion of infected cells: A way of life for HTLV-I

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue SUPPL. 1, 1996, Pages

  Wattel, Eric ^a,b   Cavrois, Marielle ^b   Gessain, Antoine ^c   Wain Hobson, Simon ^d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Institut de Recherche sur le Cancer de Lille   (France)

^c Institut Pasteur   (France)

^d INSTITUT PASTEUR   (France)

Author keywords

Adult T cell leukemia; Clonal expansion; Genetic variation; HTLV I; Tropical spastic paraparesis

Indexed keywords

TAX PROTEIN;

CELL CYCLE; CONFERENCE PAPER; GENETIC ORGANIZATION; GENETIC STABILITY; GENETIC VARIABILITY; HUMAN T CELL LEUKEMIA VIRUS 1; MITOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; SPASTIC PARAPLEGIA; T CELL LEUKEMIA; T CELL LYMPHOMA; VIREMIA; VIRUS REPLICATION;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0029759562     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199600001-00016     Document Type: Conference Paper

References (28)

1. Domingo E, Holland JJ. Complications of RNA heterogeneity for the engineering of virus vaccines and antiviral agents. In: Setlow JK, ed. Genetic engineering, principles and methods. New York: Plenum, 1992:13-31.
2. Holland JJ, de le Torre JC, Steinhauer DA. RNA virus populations as quasispecies. Curr Top Microbiol Immunol 1992; 176:1-20.
3. Eigen M. Viral quasispecies. Sci Am 1993;269:42-9.
4. Drake JW. Rates of spontaneous mutations among RNA viruses. Proc Natl Acad Sci USA 1993;90:4171-5.
5. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 1983;80:3618-22.
6. Gessain A, Gallo RC, Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol 1992;66:2288-95.
7. Myers G, Lorber B, Wain-Hobson S, Smith RF, Pavlakis GN. Los Alamos National Laboratory, Los Alamos, New Mexico, 1993.
8. Pedroza Martins L, Chenciner N, Wain-Hobson S. Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp 120 envelope sequence. Virology 1992;191:837-45.
9. Kira J, Koyanagi Y, Yamada T, et al. Increased HTLV-I proviral DNA in HTLV-I associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol 1991; 29:194-201.
10. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T cell leukemia virus type 1. J Virol 1990;64:5682-7.
11. Shinzato O, Ikeda S, Momita S, Nagata Y, Kamihira S, Nakayama E, Shiku H. Semiquantitative analysis of integrated genomes of human T-lymphotropic virus type I in asymptomatic virus carriers. Blood 1991;78:2082-8.
12. Wattel E, Mariotti M, Agis F, et al. Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/ II-seropositive blood donors of the French West Indies. J Infect Dis 1992;165:369-72.
13. Mansky LL, Temin HM. Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus. J Virol 1994;68:494-9.
14. Mansky LM, Temin HM. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995;69:5087-94.
15. Coffin J. Genetic diversity and evolution of retroviruses. Curr Top Microbiol Immunol 1992;176:143-64.
16. Pique C, Tursz T, Dokhelar MC. Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: a basis for envelope conservation? EMBO J 1990;9: 4243-8.
17. Maynard Smith J. Natural selection and the concept of a protein space. Nature 1970;225:563-4.
18. Wattel E, Vartanian JP, Pannetier C, Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 1995;69:2863-8.
19. Cavrois M, Wain-Hobson S, Wattel E. Stochastic events in the amplification of HTLV-1 integration sites by linker mediated PCR. Res Virol 1995;146:179-84.
20. Takemoto S, Matsuoka M, Yamagushi K, Takatsuki K. A novel diagnostic method of adult T cell leukemia: monoclonal integration of human T-cell leukemia virus type I provirus DNA detection by inverse polymerase chain reaction. Blood 1994;84:3080-5.
21. Yoshida M. HTLV-1 Tax: regulation of gene expression and disease. Trends Microbiol 1993;1:131-135.
22. Parker CE, Daenke S, Nightingale S, Bangham CRM. Activated HTLV-1 specific cytolytic T lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992;188:628-36.
23. + cytotoxic T lymphocytes specific for HTLV-1 pX in patients with HTLV-1 associated neurological disease. Nature 1990;349:245-8.
24. Kinoshita T, Shimoyama M, Tobinai K, et al. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type 1 in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86:5620-4.
25. Saito M, Furukawa Y, Kubota R, et al. Frequent mutation in pX region of HTLV-1 is observed in HAM/TSP patients but is not specifically associated with the central nervous system lesions. J Neurovirol 1995;1:286-94.
26. Niewiesk S, Daenke S, Parker CE, et al. Naturally occurring variants of human T-cell leukemia virus type I tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of tax. J Virol 1995;69:2649-53.
27. Yamaoka S, Tobe T, Hatanaka M. Tax protein of human T-cell leukemia virus type I is required for maintenance of the transformed phenotype. Oncogene 1992;7:433-7.
28. INK4A and counteracts its inhibitory activity towards CDK4. EMBO 1996;15:1607-14.